English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduCedars-Sinai has been named to the Honor Roll for the ninth consecutive year in U.S. News & World Report’s “Best Hospitals 2024-25” rankings.
Tag: Endocrinology
UT Southwestern once again ranked best hospital in DFW
UT Southwestern Medical Center is the No. 1 hospital in Dallas-Fort Worth for the eighth consecutive year and ranks among the nation’s top hospitals for care in 11 specialties – the most of any hospital in Texas, according to U.S. News & World Report’s annual Best Hospitals list released today.
George Bakris, internationally recognized hypertension expert, 1952-2024
Bakris served on the UChicago faculty for 18 years and was director of the Comprehensive Hypertension Center.
Researcher Wins National Award for Congenital Adrenal Hyperplasia Study
A novel Children’s Hospital Los Angeles study led by Mimi S. Kim, MD, MSc, has received the 2024 prize for Best Original Research Paper from Hormone Research in Paediatrics and the Pediatric Endocrine Society (PES)
Endocrine Society urges passage of the Right to IVF Act
The Endocrine Society endorses the Right to IVF Act, which was introduced by Senators Cory Booker (D-NJ), Patty Murray (D-WA) and Tammy Duckworth (D-IL) to protect and expand nationwide access to fertility treatment, including in vitro fertilization (IVF), and urges the Senate to pass the Right to IVF Act on June 12th to ensure that the freedom to start and grow a family is protected and accessible to everyone in the United States.
Type of weight loss surgery women undergo before pregnancy may influence children’s weight gain
The type of weight loss surgery women undergo before becoming pregnant may affect how much weight their children gain in the first three years of life, suggests a study being presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Early menopause linked to greater risk for breast, and possibly ovarian cancer
Some women who experience menopause early—before age 40—have an increased risk for developing breast and ovarian cancer, according to research being presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Telemedicine may increase endocrinology care access for under-resourced patients with diabetes and heart disease
Widespread availability of telemedicine during the pandemic led to more equitable access to endocrinology care for patients with type 2 diabetes and heart disease, according to a study being presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Two medication classes reduced cardiovascular and liver events in people with type 2 diabetes
GLP-1 receptor agonists (GLP-1s) and SGLT-2 inhibitors lower the risk of major cardiovascular events like heart attacks and severe liver complications compared to other diabetes treatments, according to data being presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Metformin may be as safe as insulin during pregnancy, 11-year data shows
Metformin is safe to use during pregnancy to manage diabetes, with no long-term adverse effects on the children born and their mothers for at least 11 years after childbirth, according to research presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass. This is the first study to look at longer term effects of metformin use during pregnancy.
Stress from living in violent neighborhoods tied to aggressive lung cancer in Black men
Exposure to increased neighborhood violence has the power to change the glucocorticoid receptor (GR) for the stress hormone, cortisol, which may influence the aggressiveness of lung cancer, according to data presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
CDC reports its decade-long efforts in standardizing vitamin D tests
Vitamin D tests certified by the U.S. Centers for Disease Control and Prevention (CDC) Clinical Standardization Programs (CSP) are well calibrated overall, according to a new study presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass. However, the researchers found some inaccuracies among the assays studied.
Persons of nonbinary gender may desire lower-dose testosterone treatment than guidelines recommend
Among transgender and gender-diverse adults whose gender identity is nonbinary—not exclusively male or female—and who choose low-dose hormone treatment, most prefer to continue testosterone therapy at lower-than-recommended doses after at least six months of treatment, a new study finds. The study will be presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Thyroid eye disease patients report maintained improvement 2 years after teprotumumab infusions
Most patients with thyroid eye disease treated with teprotumumab didn’t require additional treatments nearly 2 years later, according to industry-supported research being presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass., and published in the journal Thyroid.
More women report hip fractures earlier in life
Older women with low bone density are more likely to experience their first hip fracture in their 60s compared to older ages, according to research being presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
High insulin levels contribute to worse outcomes for Black women with aggressive form of breast cancer
High insulin levels contribute to worse outcomes for Black women compared to white women who have an aggressive form of breast cancer called triple-negative breast cancer, according to a study presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
New male birth control gel takes effect sooner than similar contraceptive methods
A novel male contraceptive gel combining two hormones, segesterone acetate (named Nestorone) and testosterone, suppresses sperm production faster than similar experimental hormone-based methods for male birth control, according to a new study.
Hot flashes in menopausal women may signal increased risk for heart and metabolic issues
Women experiencing moderate-to-severe vasomotor symptoms face a three times greater risk for metabolic-dysfunction-associated steatotic liver disease (MASLD) compared to those with mild symptom severity, according to research being presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Study finds potentially treatable factors to improve symptoms in men stopping illicit steroids
Men who illicitly used steroids to boost muscle size and physical performance and have stopped in the past year have impaired sexual function compared with men currently using steroids, according to a study being presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Almost 20% of breast cancer survivors may experience excess weight gain
Almost one out of five breast cancer survivors may experience weight gain of more than 10%, suggests a study presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass. A number of factors are associated with excessive weight gain, the researchers found.
GLP-1 medications for type 2 diabetes and obesity may lower risk of acute pancreatitis
Medications for type 2 diabetes and obesity known as GLP-1 receptor agonists may lower the risk of acute pancreatitis recurrence in people with obesity and those with type 2 diabetes, according to a study presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
People with well-controlled, long-duration type 1 diabetes may still face high risk of heart disease
People who have had type 1 diabetes for more than 50 years without kidney complications may still be at substantial risk for heart disease, despite excellent control of blood pressure, cholesterol and blood sugar levels, according to a study presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Risk for heart attack and stroke increases in people with obesity for a decade or more
People under age 50 have a greater risk for heart attack or stroke if they’ve lived with obesity for 10 years, according to industry-sponsored research being presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Anti-obesity medication tirzepatide remains effective even for those with diabetes and other complications
Having medical conditions linked to obesity does not impact the total weight loss achieved with the anti-obesity medication tirzepatide, according to an industry-supported study being presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Synthetic estrogen associated with increased anxiety-like behaviors in a rat model
The type of estrogen in hormonal birth control may influence anxiety-like behaviors, according to data presented by Abigail Hegwood, M.S., from the Prakapenka Lab at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Asian patients more likely to develop type 2 diabetes 1 year after prediabetes diagnosis compared to white and Black patients
One year after a prediabetes diagnosis, Asians were more likely to develop diabetes mellitus whereas Black patients were more likely to remain in prediabetes range, highlighting racial disparities in diabetes prevention, according to data presented at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
GLP-1 has the power to change taste sensitivity in women with obesity
Semaglutide improved taste sensitivity, changed gene expression in the tongue that’s responsible for taste perception, and changed the brain’s response to sweet tastes, according to research presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Prediabetes raises Mexicans’ risk of dying prematurely of heart or kidney disease
Prediabetes increases the risk of dying before age 75, particularly due to heart disease, kidney disease and acute diabetic complications, according to a new study presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Higher blood concentrations of testosterone are associated with reduced risk of developing type 2 diabetes in men under 65
Testosterone appears protective against developing type 2 diabetes in men who are overweight or obese and under age 65, but not in men over that age, according to a study presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Race and social vulnerability impact glycemic control in people with diabetes
People of color and those who experience social vulnerability are more likely to experience worse glycemic control than their white counterparts, according to research presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Childhood sedentariness may cause premature liver damage in young adulthood
Children who are sedentary for more than six waking hours a day have a significantly increased risk of severe fatty liver disease and liver cirrhosis by young adulthood, a new study finds. The research findings will be presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass and published in Nature’s npj Gut and Liver.
Childhood stress linked with earlier substance use in male and female teens
Stress during childhood is associated with earlier substance use in male and female adolescents, according to a study presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass. Traumatic events may increase substance use risk for males, while environmental stress and early puberty may increase the risk for females, the researchers found.
Insurance often denies GLP-1 medications for teens with type 2 diabetes, obesity
Health insurance companies often deny coverage for new medications that treat children and teens with obesity and type 2 diabetes, meaning many patients who need treatment are unable to afford it, according to a study presented at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
ENDO 2024 press conferences to highlight male birth control, anti-obesity medications
Researchers will delve into emerging research in diabetes, obesity, reproductive health and other aspects of hormone health during the Endocrine Society’s ENDO 2024 news conferences June 1-4.
Lily Ng and Douglas Forrest of NIDDK win Endocrine Society’s 2024 Endocrine Images Art Competition
The Endocrine Society is delighted to announce that Lily Ng, PhD, and Douglas Forrest, Ph.D., have won the Society’s 2024 Endocrine Images Art Competition for their image of the astrocyte cell that expresses type 2 deiodinase.
Endocrine Society and European Society of Endocrinology publish joint guideline on glucocorticoid-induced adrenal insufficiency
The joint guideline is designed to help clinicians manage patients who have, or are at risk of developing, glucocorticoid-induced adrenal insufficiency. At least 1% of the global population uses chronic glucocorticoid therapy as anti-inflammatory or immune-suppressive agents.
علاج عُقيدات الغدة الدرقية بدون جراحة
مدينة روتشستر، ولاية مينيسوتا – معظم التكتلات أو العُقيدات في الغدة الدرقية، التي هي غدة في عنقك، غير ضارة ولا تحتاج إلى علاج. ولكنها في بعض الأحيان قد تصبح أكبر وتسبب مشكلات مثل عُسر البلع. في هذه الحالات قد يحتاج الأطباء إلى إجراء جراحة لإزالتها.
People with hypothyroidism and type D personality may be more likely to experience poor treatment outcomes
New research published in The Journal of Clinical Endocrinology & Metabolism finds a high prevalence of type D personality among people with hypothyroidism.
Canton wins Wayne Bardin International Travel Award
The Endocrine Society selected Ana Canton, M.D., Ph.D., as the recipient of its 2024 C. Wayne Bardin, MD, International Travel Award for her outstanding ENDO abstract and her research contributions to the care of patients with pediatric endocrine disorders.
Nerve decompression shows promise for diabetic neuropathy patients
Surgical nerve decompression, used to treat conditions such as carpal tunnel syndrome and sciatica, could play a role in relieving the pain of diabetic neuropathy patients, researchers at UT Southwestern Medical Center found.
Endocrine Society celebrates extension of Special Diabetes Program
The Endocrine Society applauds Congress for approving the first funding increase for the Special Diabetes Program in two decades.
Endocrine Society supports federal legislation protecting IVF access
The Endocrine Society is calling for members of Congress to support federal legislation protecting access to in vitro fertilization (IVF).
Latest Science Shows Endocrine Disrupting Chemicals in Plastics, Pesticides, and Other Sources Pose Health Threats Globally
A report from the world’s leading scientific and medical experts on hormone-related health conditions raises new concerns about the profound threats to human health from endocrine disrupting chemicals (EDCs) that are ubiquitous in our surroundings and everyday lives.
ENDO 2024 opens media registration
Members of the media can now register to cover hormone health and science advances being presented at ENDO 2024, the Endocrine Society’s annual meeting. The meeting will take place June 1-4, in Boston, Mass.
Leading experts share latest science on global health threats from endocrine disrupting chemicals
As delegates from around the world meet at the sixth session of the U.N. Environmental Assembly (UNEA-6), a new report raises concerns about the profound threats to human health from endocrine-disrupting chemicals (EDCs) that are ubiquitous in our surroundings and everyday lives.
What’s on Your Plate?
The Food Pyramid that many of us learned about in school is now ancient history. That old guideline on food groups and servings has been replaced by MyPlate.
Women face greater risk of obesity in low- and middle-income countries
Women in low- and middle-income countries, especially in the Sub-Saharan Africa region, may be 10 times more likely to have obesity or heart health issues than their male counterparts, according to a large meta-analysis published in The Journal of Clinical Endocrinology and Metabolism.
Virtual Science Writers Conference will examine obesity treatments and heart health
Endocrine Society experts will discuss how these medications and bariatric surgery can treat obesity and improve cardiometabolic health, during the Society’s Virtual Science Writers Conference on November 9.
Study reveals how estrogen exerts its anti-diabetic effects
The quintessential female sex hormone estrogen stimulates cells that line blood vessels to deliver insulin to muscles, lowering blood sugar and protecting against Type 2 diabetes, UT Southwestern Medical Center researchers report. The findings, published in Nature Communications, could eventually lead to new therapies for Type 2 diabetes, a disease that affects hundreds of millions of people around the globe and continues to grow more prevalent.
Felix Beuschlein announced as winner of 2024 Transatlantic Alliance Award in Endocrinology
The Endocrine Society and the European Society of Endocrinology (ESE) are delighted to announce that they have awarded the 2024 Transatlantic Alliance Award to Professor Felix Beuschlein, MD.